Multiple Myeloma
Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma.
Dual Targeting of CDK4 and <span class="gene" id="26873845-0-27-31">ARK5</span> Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against <span class="disease" id="26873845-0-114-130">Multiple Myeloma</span>.